New drug combo tested for Tough-to-Treat lung cancer
NCT ID NCT07241767
Summary
This study is testing a new drug called FH-006 when given alongside other standard lung cancer treatments. It aims to find the safest and most effective dose and see how well it helps shrink tumors in people with advanced lung cancer that can't be cured with surgery or radiation. About 200 adults with advanced non-small cell lung cancer will participate to help researchers understand the drug's side effects and potential benefits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
Contact
Conditions
Explore the condition pages connected to this study.